It is currently Tue Sep 27, 2016 1:39 pm
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 234264 • Total topics 25188 • Total members 16407